ARVINAS, INC. ARVN
- ARV-027 — Spinal Bulbar Muscular Atrophy Phase 1
- luxdegalutamide — Metastatic Castration-Resistant Prostate Cancer Phase 2
- luxdegalutamide — Prostate Cancer Phase 1
AR (2 companies · 4 programs)
Companies with an active program directed at AR.
Eikon Therapeutics, Inc. EIKN
- EIK1006 — Prostate Cancer Preclinical